M Evo Global Acquisition Corp II
MEVOW · NASDAQ
MEVOW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 616
- Volume
- 6.52K
- Open price
- $0.2501
- High today
- $0.2501
- Low today
- $0.2499
- 52 Week high
- $0.44
- 52 Week low
- $0.28
M Evo Global Acquisition Corp II (MEVOW) at a glance
As of Oct 30, 2026, M Evo Global Acquisition Corp II (MEVOW) shares are priced at $0.2499, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.2499 and $0.2501. The current price is 0.0% above the day's low and 0.1% below its high.
Volume so far is 6.52K shares, above the average of 616 shares a day.
Over the past year M Evo Global Acquisition Corp II has ranged from $0.28 to $0.44, and now sits -19% of the way up that range.
Most active stocks
Highest trading volume today
- BURUNuburu$0.287−22.79%
- INTCIntel$65.76−28.58%
- SLGBSmart Logistics Global$0.3051+48.97%
- AXXAExxe Group$0.0006+50.00%
- RDARRaadr$0.0002+0.00%
- SOXLDirexion Shares ETF Trust$77.05−24.75%
- HUBCHub Cyber Security$0.1134−16.00%
- RWAXTAP Real Estate Technologies$0.0002+0.00%
- NVDANVIDIA$204.64−4.20%
- NVDGraniteShares ETF Trust$4.43+8.19%
- SPCXSpace Exploration Technologies$134.69−6.39%
- GTVHGolden Triangle Ventures$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$38.38+0.27%
- BHAIUBHAV Acquisition Corp II$9.98+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.05%
- LYCALycia Therapeutics$26.40−4.80%
- DAVIDAVION HEALTHCARE$1.68−37.55%
- TCXBTCGX Acquisition Corp. II$10.14−0.66%
- CTYCITY THERAPEUTICS$20.71−6.46%
- IAMIambic Therapeutics$13.43−5.95%
- AMROAmaero$5.56−3.81%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.17−0.39%
- TRXBTRex Bio$13.74+1.63%
- RTSNRetension Pharmaceuticals$11.36−3.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.